Cargando…
Pharmacogenetics of antipsychotic-induced side effects
Currently available antipsychotic drugs (APDs) carry significant, though highly variable, liability to neurologic and metabolic side effects. Pharmacogenetics approaches offer the possibility of identifying patient-specific biomarkers for predicting risk of these side effects. To date, a few single...
Autores principales: | Lencz, Todd, Malhotra, Anil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181932/ https://www.ncbi.nlm.nih.gov/pubmed/20135898 |
Ejemplares similares
-
Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014) -
Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations
por: Eum, Seenae, et al.
Publicado: (2016) -
Pharmacogenetic aspects of addictive behaviors
por: Hejazi, Nadia S.
Publicado: (2007) -
Inhibition of the reward system by antipsychotic treatment
por: Juckel, Georg
Publicado: (2016) -
Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002)